|
Oct 22
|
Pfizer Receives FDA Approval for RSV Vaccine
|
|
Oct 22
|
U.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults Aged 18 to 59 at Increased Risk for Disease
|
|
Oct 22
|
Starboard Hammers Pfizer Execs For Failing To Deliver On 'Best Pipeline' Promises
|
|
Oct 22
|
Starboard Chief Criticizes Pfizer’s R&D Investments
|
|
Oct 21
|
Here's Why Pfizer (NYSE:PFE) Has A Meaningful Debt Burden
|
|
Oct 19
|
He Made Pfizer a Household Name. Wall Street Wants More.
|
|
Apr 11
|
Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
|
|
Apr 9
|
Pfizer unveils positive phase 3 trial results for RSV vaccine
|
|
Apr 9
|
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
|
|
Apr 8
|
ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering Manager
|
|
Jan 10
|
Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
|
|
Jan 10
|
JPM's annual healthcare conference: Here's what's next for GLP-1s and the weight loss market
|